Tower Research Capital LLC (Trc) Neuronetics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Neuronetics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,788 shares of STIM stock, worth $9,432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,788
Previous 5,273
9.2%
Holding current value
$9,432
Previous $18,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding STIM
# of Institutions
113Shares Held
21.7MCall Options Held
1.58MPut Options Held
213K-
Vanguard Group Inc Valley Forge, PA2.83MShares$5.58 Million0.0% of portfolio
-
Ubs Group Ag2.16MShares$4.26 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.82MShares$3.59 Million0.01% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$3.42 Million1.44% of portfolio
-
Wexford Capital LP Greenwich, CT1.18MShares$2.32 Million0.49% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $53.2M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...